Loading…
ShapeTX combines AI, RNA technology, and synthetic biology to design programmable RNA medicines that correct genetic mutations and modulate gene expression. The company's platform uses AI to engineer viral capsids for precise delivery and stable cell lines for scalable manufacturing.
AI named Shape Therapeutics in November 2025.